Alzheimer's disease is the most common form of dementia in the western world, however there is no cure available for this devastating neurodegenerative disorder. Despite clinical and experimental evidence implicating the intestinal microbiota in a number of brain disorders, its impact on Alzheimer's disease is not known. To this end we sequenced bacterial 16S rRNA from fecal samples of Aβ precursor protein (APP) transgenic mouse model and found a remarkable shift in the gut microbiota as compared to non-transgenic wild-type mice. Subsequently we generated germ-free APP transgenic mice and found a drastic reduction of cerebral Aβ amyloid pathology when compared to control mice with intestinal microbiota. Importantly, colonization of germ-free APP transgenic mice with microbiota from conventionally-raised APP transgenic mice increased cerebral Aβ pathology, while colonization with microbiota from wild-type mice was less effective in increasing cerebral Aβ levels. Our results indicate a microbial involvement in the development of Abeta amyloid pathology, and suggest that microbiota may contribute to the development of neurodegenerative diseases.
Conflict of interest statement
The authors declare no competing financial interests.
Amyloid Precursor Protein Processing and Retinal Pathology in Mouse Models of Alzheimer's DiseaseRM Dutescu et al. Graefes Arch Clin Exp Ophthalmol 247 (9), 1213-21. PMID 19271231.Alzheimer's mouse model retinas present with different APP proteolytic products and have a significantly lower production of amyloidogenic Abeta than found in brain.
Shifts in Gut Microbiota Composition in an APP/PSS1 Transgenic Mouse Model of Alzheimer's Disease During LifespanC Bäuerl et al. Lett Appl Microbiol 66 (6), 464-471. PMID 29575030.Alzheimer's disease is a neurodegenerative disease and neuroinflammation in the central nervous system appears to have a pivotal role. Using the transgenic APP/PS1 (TG) m …
6-Methyluracil Derivatives as Acetylcholinesterase Inhibitors for Treatment of Alzheimer's DiseaseIV Zueva et al. Int J Risk Saf Med 27 Suppl 1, S69-71. PMID 26639718.Experiments showed that the most potent AChE inhibitor compound 35 (6-methyluracil derivative) permeated the blood-brain barrier, improved working memory in the APP/PS1 t …
Vaccines for Alzheimer's Disease: How Close Are We?C Janus. CNS Drugs 17 (7), 457-74. PMID 12751917. - ReviewAlzheimer's disease is a neurodegenerative disorder characterised by a progressive loss of cognitive function. Despite the considerable progress being made, a complete de …
Cognitive Impairment in Transgenic Mouse Models of Amyloid DepositionD Morgan. PMID 21204370. - ReviewThe identification of the Aβ peptide as a major component of amyloid deposited in brain vessels and subsequently of parenchymal plaques in the brains of Alzheimer’s victi …
Cited by 78 PubMed Central articles
A Gut Bacterial Amyloid Promotes α-Synuclein Aggregation and Motor Impairment in MiceTR Sampson et al. Elife 9. PMID 32043464.Amyloids are a class of protein with unique self-aggregation properties, and their aberrant accumulation can lead to cellular dysfunctions associated with neurodegenerati …
The Progress of Gut Microbiome Research Related to Brain DisordersS Zhu et al. J Neuroinflammation 17 (1), 25. PMID 31952509. - ReviewThere is increasing evidence showing that the dynamic changes in the gut microbiota can alter brain physiology and behavior. Cognition was originally thought to be regula …
Microbiota-gut-brain Axis and Toll-Like Receptors in Alzheimer's DiseaseC Lin et al. Comput Struct Biotechnol J 17, 1309-1317. PMID 31921396. - ReviewAlzheimer's disease (AD) is a multifactorial disease which involves both the periphery and central nervous system (CNS). It has been recently recognized that gut microbio …
Concomitant Memantine and Lactobacillus plantarum Treatment Attenuates Cognitive Impairments in APP/PS1 MiceQJ Wang et al. Aging (Albany NY) 12 (1), 628-649. PMID 31907339.Trimethylamine-N-oxide (TMAO) is a gut microbial metabolite that promotes Alzheimer's disease (AD) progression. Given that probiotics can alleviate AD symptoms by inhibit …
Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 Transgenic MiceS Wang et al. Sci Rep 9 (1), 19575. PMID 31862965.Alzheimer's disease (AD) is a complex disorder influenced by both genetic and environmental components and has become a major public health issue throughout the world. Ox …